Drug Trial Radar · NCT06808932
VK4-116 Phase I Study With Food-Effect
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
48
Planned (sponsor's estimate)
Start
Sep 25, 2026
Primary completion
Jul 2027
Study completion Dec 30, 2027
Sponsor
- Lead sponsor
- National Institute on Drug Abuse (NIDA)NIH
- Sponsor type
- NIH
- Collaborators
- Altasciences Company Inc.
- First posted
- Feb 5, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This first-in-human, randomized, double-blind, placebo-controlled, single ascending dose (SAD), phase I study is designed to assess the safety, tolerability and pharmacokinetics of VK4-116 in healthy volunteers in fasted and fed state.
Conditions
- Opioid Dependence
- Opioid Use Disorder (OUD)
Interventions
VK4-116Drug
D3R antagonist
PlaceboDrug
Each of the four dose groups of n=8 participants will be assigned to active drug or placebo in the ration 6:2.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Treatment-Emergent Adverse Events in Healthy Adult ParticipantsTime frame: 7 days for fasted condition, 11 days for fed condition
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Altasciences Clinical Kansas
Overland Park, Kansas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.